Ajay Kumar/LinkedIn
Mar 2, 2026, 16:09
Ajay Kumar: The Progression of HDFN – From Fetal Anemia to Kernicterus
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“As a transfusion medicine specialist, I often emphasize the importance of early Antibody Screening in pregnancy.
Haemolytic Disease of the Fetus and Newborn (HDFN) is a preventable yet potentially life-threatening condition.
Timely antenatal antibody screening, appropriate monitoring, and interventions like intrauterine transfusion (IUT) or phototherapy can save lives and prevent permanent neurological damage.
Prevention and vigilance remain our strongest tools.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions